Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Volume Loss to Dorsum of Hands clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Volume Loss to Dorsum of Hands: 1 US clinical trial tracked, none currently recruiting.

Volume Loss to Dorsum of Hands is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Goldman, Butterwick, Fitzpatrick and Groff, running 1 of these trials.

Enrollment posture brief

Registry condition volume-loss-to-dorsum-of-hands

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Volume Loss to Dorsum of (th…0%
Open-enrollment share among volume-matched conditions near Volume Loss to Dorsum of Hands

Volume Loss to Dorsum of Hands has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Volume Loss to Dorsum of Hands on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Volume Loss to Dorsum of Hands is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Volume Loss to Dorsum of Hands records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Calcium Hydroxylapatite and Placebo Device
1 trials
Calcium Hydroxylapatite and Triamcinolone acetate Other
1 trials

US sites by state

Facility locations filed on Volume Loss to Dorsum of Hands trials. A trial with sites in several states counts in each.

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Volume Loss to Dorsum of Hands page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Volume Loss to Dorsum of Hands condition card totals 1 registered trials; most-linked intervention Calcium Hydroxylapatite and Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.